Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia

New England Journal of Medicine

Volumn 360, Issue 17, 2009, Pages 1787-1788

  Medeiros, Bruno C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; IKAROS TRANSCRIPTION FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; GENE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; HUMAN; IKZF1 GENE; LETTER; PRIORITY JOURNAL; PROGNOSIS; WILD TYPE;

GENE DELETION; GENE EXPRESSION PROFILING; GENES, ABL; HUMANS; IKAROS TRANSCRIPTION FACTOR; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS;

EID: 65949092215     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc090454     Document Type: Letter

References (2)

1. Mullighan CG, Su X, Zhang J, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009;360:470-480
2. Mullighan CG, Miller CB, Radtke I, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 2008;453:110-114